EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C29H27F3N6O |
| Net Charge | 0 |
| Average Mass | 532.570 |
| Monoisotopic Mass | 532.21984 |
| SMILES | Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12 |
| InChI | InChI=1S/C29H27F3N6O/c1-20-5-6-22(16-21(20)8-10-25-18-33-27-4-3-11-34-38(25)27)28(39)35-24-9-7-23(26(17-24)29(30,31)32)19-37-14-12-36(2)13-15-37/h3-7,9,11,16-18H,12-15,19H2,1-2H3,(H,35,39) |
| InChIKey | PHXJVRSECIGDHY-UHFFFAOYSA-N |
| Wikipedia |
|---|
| Roles Classification |
|---|
| Chemical Role: | Bronsted base A molecular entity capable of accepting a hydron from a donor (Brønsted acid). |
| Biological Role: | tyrosine kinase inhibitor Any protein kinase inhibitor that interferes with the action of tyrosine kinase. |
| Application: | antineoplastic agent A substance that inhibits or prevents the proliferation of neoplasms. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| ponatinib (CHEBI:78543) has role antineoplastic agent (CHEBI:35610) |
| ponatinib (CHEBI:78543) has role tyrosine kinase inhibitor (CHEBI:38637) |
| ponatinib (CHEBI:78543) is a (trifluoromethyl)benzenes (CHEBI:83565) |
| ponatinib (CHEBI:78543) is a N-methylpiperazine (CHEBI:46920) |
| ponatinib (CHEBI:78543) is a acetylenic compound (CHEBI:73474) |
| ponatinib (CHEBI:78543) is a benzamides (CHEBI:22702) |
| ponatinib (CHEBI:78543) is a imidazopyridazine (CHEBI:48382) |
| ponatinib (CHEBI:78543) is conjugate base of ponatinib(1+) (CHEBI:191939) |
| Incoming Relation(s) |
| ponatinib(1+) (CHEBI:191939) is conjugate acid of ponatinib (CHEBI:78543) |
| IUPAC Name |
|---|
| 3-(imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methyl-N-{4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl}benzamide |
| INNs | Source |
|---|---|
| ponatinib | WHO MedNet |
| ponatinib | WHO MedNet |
| ponatinibum | WHO MedNet |
| ponatinib | WHO MedNet |
| Synonyms | Source |
|---|---|
| AP 24534 | ChemIDplus |
| AP24534 | ChemIDplus |
| AP-24534 | ChEBI |
| Manual Xrefs | Databases |
|---|---|
| D09950 | KEGG DRUG |
| US2014038920 | Patent |
| Ponatinib | Wikipedia |
| LSM-1151 | LINCS |
| 4716 | DrugCentral |
| DB08901 | DrugBank |
| HMDB0240214 | HMDB |
| Registry Numbers | Sources |
|---|---|
| Reaxys:12923700 | Reaxys |
| CAS:943319-70-8 | KEGG DRUG |
| CAS:943319-70-8 | ChemIDplus |
| Citations |
|---|